Molecular immune pathogenesis and diagnosis of COVID-19

Journal of Pharmaceutical Analysis

Volumn 10, Issue 2, 2020, Pages 102-108

  Li, Xiaowei ^a,b   Geng, Manman ^a,b   Peng, Yizhao ^a,b   Meng, Liesu ^a,b   Lu, Shemin ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Coronavirus; MERS CoV; Pathogenesis; SARS CoV; SARS CoV 2

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; REMDESIVIR; VIRUS VACCINE;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; CYTOKINE STORM; DIAGNOSTIC PROCEDURE; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNOPATHOGENESIS; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEIC ACID ANALYSIS; PLASMA TRANSFUSION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; THORAX RADIOGRAPHY; VACCINATION; VIROLOGY; VIRUS ENTRY; VIRUS ETIOLOGY; VIRUS PATHOGENESIS; VIRUS PNEUMONIA; VIRUS REPLICATION; X-RAY COMPUTED TOMOGRAPHY;

EID: 85081948804     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpha.2020.03.001     Document Type: Review

References (73)

1. Zhou, P., Yang, X.L., Wang, X.G., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 10.1038/s41586-020-2012-7.
2. de Wit, E., van Doremalen, N., Falzarano, D., et al. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 (2016), 523–534, 10.1038/nrmicro.2016.81.
3. Wu, J.T., Leung, K., Leung, G.M., Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 2020, 10.1016/S0140-6736(20)30260-9.
4. Su, S., Wong, G., Shi, W., et al. Epidemiology, Genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24 (2016), 490–502, 10.1016/j.tim.2016.03.003.
5. Perlman, S., J. Netland Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7 (2009), 439–450, 10.1038/nrmicro2147.
6. Lu, R., Zhao, X., Li, J., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020, 10.1016/S0140-6736(20)30251-8.
7. Fehr, A.R., Perlman, S., Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282 (2015), 1–23, 10.1007/978-1-4939-2438-7_1.
8. Masters, P.S., The molecular biology of coronaviruses. Adv. Virus Res. 66 (2006), 193–292, 10.1016/S0065-3527(06)66005-3.
9. Knoops, K., Kikkert, M., Worm, S.H., et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol., 6, 2008, 10.1371/journal.pbio.0060226 e226.
10. Li, W., Moore, M.J., Vasilieva, N., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003), 450–454, 10.1038/nature02145.
11. Ge, X.Y., Li, J.L., Yang, X.L., et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503 (2013), 535–538, 10.1038/nature12711.
12. Chinese SARS Molecular Epidemiology Consortium. Chinese Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303 (2004), 1666–1669, 10.1126/science.1092002.
13. Raj, V.S., Mou, H., Smits, S.L., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495 (2013), 251–254, 10.1038/nature12005.
14. Barlan, A., Zhao, J., Sarkar, M.K., et al. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J. Virol. 88 (2014), 4953–4961, 10.1128/JVI.00161-14.
15. Huang, C., Wang, Y., Li, X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 10.1016/S0140-6736(20)30183-5.
16. Peiris, J.S., Guan, Y., Yuen, K.Y., Severe acute respiratory syndrome. Nat. Med. 10 (2004), S88–S97, 10.1038/nm1143.
17. Wu, F., Zhao, S., Yu, B., et al. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 10.1038/s41586-020-2008-3.
18. Jeffers, S.A., Tusell, S.M., Gillim-Ross, L., et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 15748–15753, 10.1073/pnas.0403812101.
19. Simmons, G., Reeves, J.D., Rennekamp, A.J., et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 4240–4245, 10.1073/pnas.0306446101.
20. Belouzard, S., Chu, V.C., Whittaker, G.R., Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 5871–5876, 10.1073/pnas.0809524106.
21. Millet, J.K., Whittaker, G.R., Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 15214–15219, 10.1073/pnas.1407087111.
22. Wang, H., Yang, P., Liu, K., et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 18 (2008), 290–301, 10.1038/cr.2008.15.
23. Kuba, K., Imai, Y., Ohto-Nakanishi, T., et al. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther. 128 (2010), 119–128, 10.1016/j.pharmthera.2010.06.003.
24. Liu, J., Wu, P., Gao, F., et al. Novel immunodominant peptide presentation strategy: a featured HLA-A∗2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Virol. 84 (2010), 11849–11857, 10.1128/JVI.01464-10.
25. Keicho, N., Itoyama, S., Kashiwase, K., et al. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum. Immunol. 70 (2009), 527–531, 10.1016/j.humimm.2009.05.006.
26. Chen, Y.M., Liang, S.Y., Shih, Y.P., et al. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J. Clin. Microbiol. 44 (2006), 359–365, 10.1128/JCM.44.2.359-365.2006.
27. Wang, S.F., Chen, K.H., Chen, M., et al. Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol. 24 (2011), 421–426, 10.1089/vim.2011.0024.
28. Hajeer, A.H., Balkhy, H., Johani, S., et al. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann. Thorac. Med. 11 (2016), 211–213, 10.4103/1817-1737.185756.
29. Tu, X., Chong, W.P., Zhai, Y., et al. Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection. J. Infect. 71 (2015), 101–109, 10.1016/j.jinf.2015.03.006.
30. Li, G., Chen, X., Xu, A., Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349 (2003), 508–509, 10.1056/NEJM200307313490520.
31. Xu, Z., Shi, L., Wang, Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp. Med., 2020, 10.1016/S2213-2600(20)30076-X.
32. Fan, Y.Y., Huang, Z.T., Li, L., et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch. Virol. 154 (2009), 1093–1099, 10.1007/s00705-009-0409-6.
33. Tang, F., Quan, Y., Xin, Z.T., et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J. Immunol. 186 (2011), 7264–7268, 10.4049/jimmunol.0903490.
34. Zhao, J., Li, K., Wohlford-Lenane, C., et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 4970–4975, 10.1073/pnas.1323279111.
35. Williams, A.E., Chambers, R.C., The mercurial nature of neutrophils: still an enigma in ARDS?. Am. J. Physiol. Lung Cell Mol. Physiol. 306 (2014), L217–L230, 10.1152/ajplung.00311.2013.
36. Channappanavar, R., Perlman, S., Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39 (2017), 529–539, 10.1007/s00281-017-0629-x.
37. Cameron, M.J., Bermejo-Martin, J.F., Danesh, A., et al. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res. 133 (2008), 13–19, 10.1016/j.virusres.2007.02.014.
38. Min, C.K., Cheon, S., Ha, N.Y., et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci. Rep., 6, 2016, 25359, 10.1038/srep25359.
39. Snijder, E.J., van der Meer, Y., Zevenhoven-Dobbe, J., et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 80 (2006), 5927–5940, 10.1128/JVI.02501-05.
40. Channappanavar, R., Fehr, A.R., Vijay, R., et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19 (2016), 181–193, 10.1016/j.chom.2016.01.007.
41. Channappanavar, R., Fehr, A.R., Zheng, J., et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J. Clin. Invest. 130 (2019), 3625–3639, 10.1172/JCI126363.
42. Niemeyer, D., Zillinger, T., Muth, D., et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 87 (2013), 12489–12495, 10.1128/JVI.01845-13.
43. Yang, Y., Zhang, L., Geng, H., et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4 (2013), 951–961, 10.1007/s13238-013-3096-8.
44. Menachery, V.D., Schafer, A., Burnum-Johnson, K.E., et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proc. Natl. Acad. Sci. U.S.A. 115 (2018), E1012–E1021, 10.1073/pnas.1706928115.
45. Corman, V.M., Landt, O., Kaiser, M., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill., 25, 2020, 10.2807/1560-7917.ES.2020.25.3.2000045.
46. Chu, D.K.W., Pan, Y., Cheng, S.M.S., et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin. Chem., 2020, 10.1093/clinchem/hvaa029.
47. To, K.K., Tsang, O.T., Chik-Yan Yip, C., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis., 2020, 10.1093/cid/ciaa149.
48. Woo, P.C., Lau, S.K., Wong, B.H., et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 43 (2005), 3054–3058, 10.1128/JCM.43.7.3054-3058.2005.
49. Xie, X., Zhong, Z., Zhao, W., et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology, 2020, 200343, 10.1148/radiol.2020200343.
50. Yam, W.C., Chan, K.H., Poon, L.L., et al. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J. Clin. Microbiol. 41 (2003), 4521–4524, 10.1128/jcm.41.10.4521-4524.2003.
51. Pan, Y., Guan, H., Zhou, S., et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur. Radiol., 2020, 10.1007/s00330-020-06731-x.
52. Shi, H., Han, X., Zheng, C., Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China. Radiology, 2020, 200269, 10.1148/radiol.2020200269.
53. Chung, M., Bernheim, A., Mei, X., et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology, 2020, 200230, 10.1148/radiol.2020200230.
54. Ooi, G.C., Khong, P.L., Muller, N.L., et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 230 (2004), 836–844, 10.1148/radiol.2303030853.
55. Ajlan, A.M., Ahyad, R.A., Jamjoom, L.G., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am. J. Roentgenol. 203 (2014), 782–787, 10.2214/AJR.14.13021.
56. Zumla, A., Chan, J.F., Azhar, E.I., et al. Coronaviruses - drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15 (2016), 327–347, 10.1038/nrd.2015.37.
57. Groneberg, D.A., Hilgenfeld, R., Zabel, P., Molecular mechanisms of severe acute respiratory syndrome (SARS). Respir. Res., 6, 2005, 8, 10.1186/1465-9921-6-8.
58. Lo, M.K., Jordan, R., Arvey, A., et al. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci. Rep., 7, 2017, 43395, 10.1038/srep43395.
59. Sheahan, T.P., Sims, A.C., Leist, S.R., et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun., 11, 2020, 222, 10.1038/s41467-019-13940-6.
60. de Wit, E., Feldmann, F., Cronin, J., et al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc. Natl. Acad. Sci. U.S.A., 2020, 10.1073/pnas.1922083117.
61. Lo, M.K., Feldmann, F., Gary, J.M., et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Sci. Transl. Med., 11, 2019, 10.1126/scitranslmed.aau9242.
62. Holshue, M.L., DeBolt, C., Lindquist, S., et al. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med., 2020, 10.1056/NEJMoa2001191.
63. Wang, M., Cao, R., Zhang, L., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res., 2020, 10.1038/s41422-020-0282-0.
64. De Clercq, E., New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem. Asian J. 14 (2019), 3962–3968, 10.1002/asia.201900841.
65. Chen, Y., Liu, Q., Guo, D., Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92 (2020), 418–423, 10.1002/jmv.25681.
66. Chen, L., Gui, C., Luo, X., et al. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 79 (2005), 7095–7103, 10.1128/JVI.79.11.7095-7103.2005.
67. Jo, S., Kim, S., Shin, D.H., et al. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 35 (2020), 145–151, 10.1080/14756366.2019.1690480.
68. Park, J.Y., Jeong, H.J., Kim, J.H., et al. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol. Pharm. Bull. 35 (2012), 2036–2042, 10.1248/bpb.b12-00623.
69. Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J.K., et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J. Infect. Dis. 211 (2015), 80–90, 10.1093/infdis/jiu396.
70. Koenig, K.L., Identify-Isolate-Inform: a modified tool for initial detection and management of Middle East Respiratory Syndrome patients in the emergency department. West. J. Emerg. Med. 16 (2015), 619–624, 10.5811/westjem.2015.7.27915.
71. Tian, X., Li, C., Huang, A., et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microb. Infect. 9 (2020), 382–385, 10.1080/22221751.2020.1729069.
72. Zhang, L., Liu, Y., Potential interventions for novel coronavirus in China: a systematic review. J. Med. Virol., 2020, 10.1002/jmv.25707.
73. Graham, R.L., Donaldson, E.F., Baric, R.S., A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 11 (2013), 836–848, 10.1038/nrmicro3143.